Ireland· IE-PA-EU/1/17/1222/001-002
Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan 600 mg/200 mg/245 mg film-coated tablets
A emtricitabine, tenofovir disoproxil and efavirenz product containing efavirenz + tenofovir disoproxil maleate + emtricitabine, registered in Ireland by Mylan Pharmaceuticals Limited. The same ATC class is registered in 13 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir disoproxil and efavirenz is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR06 (emtricitabine, tenofovir disoproxil and efavirenz), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir disoproxil and efavirenz · ATC J05AR06
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Efavirenz + Tenofovir disoproxil maleate + Emtricitabine
- Manufacturer
- Mylan Pharmaceuticals Limited
- Country
- Ireland (IE)
- ATC code
- J05AR06
- ATC class
- Emtricitabine, tenofovir disoproxil and efavirenz
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/17/1222/001-002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for emtricitabine, tenofovir disoproxil and efavirenz.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Emtricitabine, tenofovir disoproxil and efavirenz · interactions on record
4 records
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Emtricitabine, tenofovir disoproxil and efavirenz in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAtriplaOrifarm Oy
- GermanyEfavemtenTad Pharma Gmbh
- FranceATRIPLA 600 mg/200 mg/245 mg, comprimé pelliculéGILEAD SCIENCES IRELAND UC (IRLANDE)
- CzechiaEFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL KRKAKrka, d.d., Novo mesto, Novo mesto
- United Statesefavirenz, emtricitabine and tenofovir disoproxil fumarateCipla USA Inc.
- United KingdomAtripla 600mg/200mg/245mg tabletsGilead Sciences Ltd
- CanadaAPO-EFAVIRENZ-EMTRICITABINE-TENOFOVIRAPOTEX INC
- SwedenEfavirenz/Emtricitabine/Tenofovir disoproxil Glenmark 600 mg/200 mg/245 mg Filmdragerad tablettGlenmark Arzneimittel GmbH
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Efavirenz/Emtricitabin/Tenofovirdisoproxil Ratiopharm
- Germany · Efavemten, Efavirenz/Emtricitabin/Tenofovirdisoproxil Aliud
- Denmark · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark, Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
- Estonia · Efavirenz/Emtricitabine/Tenofovir Disoproxil Zentiva K.S., Padviram
- Spain · Efavirenz/Emtricitabina/Tenofovir Disoproxilo Aurovitas, Efavirenz/Emtricitabina/Tenofovir Disoproxilo Dr. Reddys
- Finland · Fatrino
- France · Efavirenz/Emtricitabine/Tenofovir Disoproxil Arrow, Efavirenz/Emtricitabine/Tenofovir Disoproxil Bgr
- United Kingdom (Northern Ireland) · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark Pharmaceuticals Europe, Efavirenz/Emtricitabine/Tenofovir Disoproxil Macleods
- Croatia · Efavirenz/Emtricitabin/Tenofovirdizoproksil Stada
- Iceland · Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka, Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan
- Italy · Efavirenz E Emtricitabina E Tenofovir Disoproxil Aurobindo, Efavirenz/Emtricitabina/Tenofovir Disoproxil Zentiva K.S.
- Liechtenstein · Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan 600 Mg/200 Mg/245 Mg Film-Coated Tablets Mylan
- Netherlands · Efavirenz/ Emtricitabine/ Tenofovir Disoproxyl Fumarate Aurobindo, Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark
- Norway · Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka, Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan
- Poland · Efavirenz + Emtricitabine + Tenofovir Disoproxil Aurovitas
- Portugal · Efavirenz + Emtricitabina + Tenofovir Generis, Efavirenz + Emtricitabina + Tenofovir Teva
- Romania · Efavirenz/Emtricitabină/Tenofovir Disoproxil Zentiva K.S.
- Sweden · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark, Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e31d2f90-caca-4b63-8973-f298c1fe39af GET /v1/drugs/e31d2f90-caca-4b63-8973-f298c1fe39af?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"J05AR",
"J05AR06"
],
"strength": null,
"pa_number": "EU/1/17/1222/001-002",
"substances": [
"Efavirenz",
"Tenofovir disoproxil maleate",
"Emtricitabine"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "05/09/2017",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about emtricitabine, tenofovir disoproxil and efavirenz.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.